{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "2573817",
  "DateCompleted": {
    "Year": "1989",
    "Month": "12",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "jpn"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0301-4894",
      "JournalIssue": {
        "Volume": "90",
        "Issue": "9",
        "PubDate": {
          "Year": "1989",
          "Month": "Sep"
        }
      },
      "Title": "Nihon Geka Gakkai zasshi",
      "ISOAbbreviation": "Nihon Geka Gakkai Zasshi"
    },
    "ArticleTitle": "[Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].",
    "Pagination": {
      "StartPage": "1579",
      "EndPage": "1581",
      "MedlinePgn": "1579-81"
    },
    "Abstract": {
      "AbstractText": [
        "We investigated the amplification and expression of oncogenes in human cancerous and noncancerous tissues, and clarified the correlation between the biological characteristics and them. Amplification of c-erb B oncogene is detected in 12% of squamous cancer tissues such as cancer of the lung and esophagus, but not others. That of c-erb A and c-erb B-2 oncogenes is, specifically, detected in 20-25% of breast cancers. On the other hand, amplification of c-myc is detected in 10-20% of various cancers. EGF receptors is highly and specifically, overexpressed in squamous cancers, and the prognosis of the patients with amplification and overexpression of c-erb B oncogenes is poor."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dept. Surg. School of Medicine Keio University, Tokyo, Japan."
          }
        ],
        "LastName": "Ueda",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shimizu",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Abe",
        "ForeName": "O",
        "Initials": "O"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Nihon Geka Gakkai Zasshi",
    "NlmUniqueID": "0405405",
    "ISSNLinking": "0301-4894"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Proto-Oncogene Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Thyroid Hormone"
    },
    {
      "RegistryNumber": "EC 2.7.10.1",
      "NameOfSubstance": "ErbB Receptors"
    },
    {
      "RegistryNumber": "EC 2.7.10.1",
      "NameOfSubstance": "Receptor, ErbB-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "ErbB Receptors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Amplification"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Organ Specificity"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Proto-Oncogene Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Proto-Oncogenes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Receptor, ErbB-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Receptors, Thyroid Hormone"
    }
  ]
}